Details of the Drug

General Information of Drug (ID: DML5JG9)

• Drug Name: CAM-101

Indication

Disease Entry	ICD 11	Status	REF
Keratoconjunctivitis sicca	9A79	Phase 1/2	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: DZU9Q5

References

• [1] ClinicalTrials.gov (NCT03414645) Randomized Multicenter Double-Masked Placebo-Controlled Parallel Phase I/II Study to Determine the Safety and Exploratory Efficacy of Topical Fibrinogen Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs Host Disease. U.S.National Institutes of Health.